We describe a novel disease entity with the clinical and radiologic presentation of neuromyelitis optica (NMO) and widespread CD8-positive T-cell leukoencephalitis and astrocytopathy. The 59-year-old female patient had a complex 2-year neurological history that included early changes in cognition and memory, progressive lower extremity motor dysfunction, and multimodal sensory involvement. MRI of the spinal cord showed increased T2 signal in the central cord extending from C2 through T4. MRI of the brain showed symmetric radial enhancement in periventricular deep white matter without evidence of demyelinating lesions. The constellation of findings met clinical criteria for NMO. Steroid treatment was initiated with subjective improvement but she developed urosepsis and died at age 61 years. At autopsy, the spinal cord showed typical NMO findings but no evidence of complement deposition or neutrophil infiltration. There was diffuse CD8-positive T-cell infiltration and CD68-positive macrophage activation throughout subcortical white matter, optic chiasm, brainstem, and spinal cord. This was accompanied by marked astrocytopathy in all areas. Serum was negative for aquaporin-4 autoantibodies suggesting a nonhumoral basis of astrocyte damage. This first example of CD8-positive T-cell leukoencephalitis in a patient with a clinical presentation of NMO may explain the recalcitrance of some patients to therapies targeting humoral immunity.
INTRODUCTION
Neuromyelitis optica spectrum disorder (NMOSD) is an emerging concept of autoimmune disease affecting the central nervous system (CNS) (1) . Autoantibodies against the water channel aquaporin-4 (AQP4), which is highly expressed on astrocytic foot processes at the blood-brain barrier (BBB), both define the disease entity and render astrocytes the target of immune attack. The resultant astrocytopathy in NMO inflammatory lesions includes a variety of astrocyte pathology and is the proposed mechanism of CNS injury and dysfunction (2) . The inciting event allowing for the development AQP4 autoantibodies and their subsequent access to the CNS is unknown but experimental models suggest AQP4-specific CD4-positive T cells may assist by inducing inflammation resulting in breakdown of the BBB (3) .
It is now recognized that the clinical and pathologic features of NMO include a spectrum of brain lesions. Current consensus criteria for the diagnosis of NMO include core clinical characteristics, typical MRI features, and stratify groups by the presence or absence of serum AQP4 immunoglobulin G (IgG) (4) . Over half of patients present with brain lesions at symptom onset; and symptoms can be attributed to involvement of circumventricular regions (area postrema), brainstem, diencephalon, or cerebrum (5) . MRI of the brain may show nonspecific white matter lesions often with "cloud-like" enhancement, as well as hypothalamic, corpus callosal, periventricular, circumventricular, and brainstem lesions (6) .
Six NMOSD lesion types were described by Misu et al (7) . The classic histopathologic features of NMOSD lesions include extensive demyelination with associated necrosis and cavitation at multiple spinal cord levels and within the optic nerve and/or chiasm (8) . Acute lesions are characterized by marked macrophage infiltration, axon spheroids, loss of axons, loss of oligodendrocytes, and necrosis of both gray and white matter typically within the central spinal cord. In addition to macrophages, the inflammatory infiltrate typically includes numerous B cells and rare T cells. Active lesions often show perivascular deposition of immunoglobulins and complement, as well as marked perivascular eosinophilic and neutrophilic infiltrates in early lesions. Chronic lesions are characterized by cystic degeneration, cavitation, atrophy, and gliosis.
Astrocytes are considered to be the primary target in NMO lesions and a range of astrocytic pathology has been described, including loss, dystrophic morphology, mitoses, multinucleation, and the presence of bipolar progenitor cells (2) . Astrocytic clasmatodendrosis and phagocytosis of glial fibrillary acidic protein (GFAP) by macrophages have also been reported (7) . Both cortical and white matter astrocytes express AQP4 but NMO lesions typically involve periventricular regions and white matter tracts. The basis of this selectivity is unknown.
We report the case of a patient who clinically and radiologically had a disease compatible with NMO but in which the neuropathological examination at autopsy unexpectedly was associated with widespread CD8-positive T-cell leukoencephalitis and astrocytopathy in addition to more typical pathologic findings in the spinal cord. B cells, eosinophils, neutrophils, and complement deposition were absent raising the possibility of a T-cell mediated rather than humoral-based astrocytopathy.
MATERIALS AND METHODS

Case History
The patient was a 59-year-old previously healthy woman who developed impaired memory, confusion, poor coordination, and bilateral lower extremity weakness that progressed over a 20-month period. During the course of her disease, she also exhibited poor balance, dizziness, paresthesias, and multiple falls. She developed vivid frightening dreams, intermittent episodes of emesis and a 60-pound weight loss. There were additional constitutional symptoms including fatigue, myalgias, and chills. There was no family history of neurodegenerative or autoimmune disease.
Due to progressive symptoms, she required inpatient admission for evaluation of cognitive and motor decline approximately 6 months after the onset. At that time, her examination was notable for relatively preserved strength, mild incoordination of lower extremities, diffusely increased tone and hyperreflexia, broad based gait, and stooped posture. Serum electrolytes, renal function tests, and CBC were unremarkable. The patient had a low-normal B12 level (312 pg/ mL); homocysteine and methylmalonic acid testing were not done. Also within normal range were HbA1c, TSH, and free T4. Rheumatologic workup, imaging for occult malignancy, and serologic testing for paraneoplastic syndromes were also negative. Cerebrospinal fluid (CSF) analysis showed lymphocytic pleocytosis with WBC 73 (98% lymphs), RBC 2, normal glucose 56 mg/dL, and elevated protein at 144 mg/dL. IgG was mildly elevated to 6.3 mg/dL (normal range: 0-6.1), with absent oligoclonal bands. CSF testing for an infectious process was negative and included VDRL, CMV, HIV, West Nile virus, enterovirus, Lyme, cryptococcal antigen, AFB, bacterial, and fungal cultures. CSF paraneoplastic antibody panel was negative; flow cytometry of CSF showed predominantly Tlymphocytes (CD4-positive > CD8-positive), without evidence of malignancy. A formal diagnosis was not reached. She was discharged home with supportive care.
The patient suffered further decline in subsequent months, becoming nonambulatory with inability to perform basic selfcare activities. Her course was complicated by recurrent urinary tract infections and decubitus ulcer formation, with multiple admissions for suspected sepsis. Repeat neurologic evaluation approximately 18 months after her initial presentation was notable for relatively intact upper extremity strength with significant weakness in her lower extremities, rated 1-2/5 on individual motor testing, diffuse muscular atrophy without fasciculations, and diffusely brisk reflexes with sustained clonus. Sensation was decreased to all modalities (pinprick, light touch, vibration, position, and temperature) with a T6 sensory level. An eventual trial of high dose steroids was implemented (methylprednisolone 1 g IV Â 5 days with an oral taper) after repeat MR imaging and clinical evaluation showed overall progression of the underlying disease process. The patient's spouse reported modest response to corticosteroids with subjective improvement in mental status, lower extremity weakness, and sensation.
Unfortunately, shortly thereafter she developed severe urosepsis requiring transfer to an intensive care unit at a tertiary care center. Neurologic examination limited by intubation was notable for decreased level of arousal and diffuse motor weakness in all extremities, right greater than left, without antigravity movement. She failed to improve despite a prolonged hospital course and her family elected to focus on comfort care. She died approximately 20 months after her first presentation.
MRI
Routine pre and postgadolinium based contrast MRI was performed on a Siemens 1.5T scanner approximately 6 months after initial presentation. Clinical 3-direction diffusion weighted imaging of the brain was obtained with acquisition parameters of 5 mm slice thickness, 6.5 mm spacing; apparent diffusion coefficient (ADC) maps were calculated. Anatomic imaging of the brain included axial T2-FLAIR, axial T1, axial T1 postcontrast, and coronal T1 postcontrast T1 sequences with acquisition parameters of 5 mm slice thickness and 7 mm spacing. Anatomic imaging of the cervical spine included sagittal T2 STIR and sagittal and axial T1 pre and postcontrast sequences with acquisition parameters of 3 mm slice thickness and 4 mm spacing. T2 weighted sagittal sequences of the thoracic spine were also obtained with acquisition parameters of 4 mm slice thickness and 5 mm spacing.
Autopsy
Systemic, brain and spinal cord tissues were collected at autopsy. The fixed brain and cord were examined grossly and photographed before sectioning in the coronal plane. After cassetting and paraffin embedding, 6-mm-thick sections were cut and stained for routine histological analysis.
Immunohistochemistry
Immunostaining was performed as previously described (9) . Formalin-fixed paraffin-embedded sections were stained using antibodies for specific markers of cell lineage as follows: GFAP (1:1000, rabbit polyclonal; Dako, Carpinteria, CA), CD68 (1:100, KP1; Dako), CD3 (1:500, rabbit polyclonal; Dako), TIA1 (1:50, mouse monoclonal; Beckman Coulter, Indianapolis, IN), CD8 (1:40, mouse monoclonal; Dako), granzyme B (1:25, mouse monoclonal; Dako), CD4 (predilute, mouse monoclonal; Ventana, Tucson, AZ), CD20/ L26 (predilute, mouse monoclonal; Ventana), neurofilament (predilute, mouse monoclonal; Ventana), amyloid precursor protein (APP) (1:400, Millipore; Billerica, MA), phospho-tau (PHF-1, courtesy of Dr. Peter Davies, Hofstra Northwell School of Medicine), a-synuclein (1:300, mouse monoclonal, Life Technologies, Carlsbad, CA), AQP1 (1:1000, rabbit polyclonal, Atlas Antibodies, Bromma, Sweden), AQP4 (1:1000, goat polyclonal, Santa Cruz Biotechnology, Dallas, TX), and OLIG2 (1:1000, rabbit polyclonal, EMD Millipore).
Double Immunofluorescence Labels
Slides were deparaffinized with histo-clear (3 Â 5 minutes). After washes in 2Â 100% EtOH, 95% EtOH, 70% EtOH, and PBS (5 minutes 
Electron Microscopy
After fixation in 10% formalin, spinal cord tissue was postfixed in Karnovsky's fixative (1.5% glutaraldehyde and 2% paraformaldehyde in sodium phosphate buffer), followed by 1% osmium tetroxide before embedding in Epon araldite. Sections, 0.5 mm thick, were made and stained with toluidine blue. Thin sections were stained with lead citrate and uranyl acetate.
RESULTS
MRI Findings
Significant findings included periventricular and subcortical white matter edema evident by vague hyperintensity on the T2-FLAIR and diffusion weighted images without ADC correlate to suggest an infarct (Fig. 1 ). There was a striking symmetric, radial pattern of enhancement in the periventricular and subcortical white matter (Fig. 1E, F) . Curvilinear enhancement extended peripherally into gyral subcortical white matter.
In the cervical and thoracic spine, there was long segment parasagittal, intramedullary T2 signal hyperintensity with mild cord expansion and relative sparing of the cervical midline dorsal columns and ventral cord (Fig. 2) . In a similar distribution, there was extensive, heterogeneous enhancement with a shaggy texture comprised of numerous curvilinear regions of enhancement.
Autopsy Findings
A complete autopsy revealed bilateral bronchoalveolar pneumonia and no evidence of clinically undetected malignancy. Neuropathologic examination was significant for global brain atrophy (990 g) and moderate symmetrical ventricular enlargement (Fig. 3A) . The right optic nerve showed central cavitation and discoloration (Fig. 3B) . The cervical and high thoracic spinal cord was collapsed in the anteriorposterior dimension with grossly apparent central cavitation consistent with prior MRI findings (Fig. 3C) . Serum collected at autopsy was negative for AQP4 IgG by cell binding assay (Mayo Clinic, Rochester, MN), although notably the patient had received recent high dose steroid treatment and the specimen was tested outside of validated test parameters due to sample hemolysis.
Microscopic evaluation of the involved spinal cord revealed extensive and predominantly white matter destruction. There was marked vacuolization and edema of the dorsal columns adjacent to the central gray matter and central canal, and to a lesser extent, the lateral columns of multiple cervical and upper thoracic levels (Fig. 4A, E) . Luxol fast blue/periodic acid Schiff (LFB/PAS) stain highlighted decreased staining of the dorsal columns (Fig. 4B ) and lateral columns, but neurofilament staining of axons was relatively preserved (Fig. 4F) . In the same areas, there was diffuse infiltration by CD68-positive macrophages (Fig. 4C, G) and cytotoxic CD8-positive T cells (Fig. 4H) , which expressed activation markers TIA-1 (Fig. 4I ) and granzyme B (not shown). GFAP immunostaining was markedly abnormal and showed overall increased staining not limited by cell processes and decreased staining in the central vacuolated areas (Fig. 4D) . Intact astrocytes were limited to the cord perimeter of the cervical and upper thoracic levels. The few residual astrocytes were highly dystrophic with loss of almost all cell processes (Fig. 4J) . Both AQP 1 and AQP4 immunostaining were overall decreased in the central cord regions.
Double immunofluorescence staining for Iba1-positive microglia/macrophages and GFAP showed diffuse macrophage infiltration and rare astrocyte cell bodies but no evidence of phagocytosis of GFAP (Fig. 4K) . Cyto-architecture preservation in the spinal cord was inadequate and did not permit quantification of oligodendroglial nuclei by Olig2 staining.
The lumbar cord also showed mild edema and focal necrosis, with increased perivascular and leptomeningeal CD8-positive T cells within the lateral columns, but not dorsal columns. The peripheral nerve branches were unremarkable.
Sections of the spinal cord were submitted for electron microscopy. Plastic embedded thick sections of the dorsal column showed extracellular edema with abundant debris, occasional infiltrating macrophages and fiber dropout but with preservation of some myelinated axons (Supplementary Data  Fig. S1A, B) . Ultrastructural morphology was severely disrupted; however, scattered intact myelinated fibers were detected. Within the highly edematous cord parenchyma, bundles of intermediate filaments not bound by membrane processes were noted.
Evaluation of multiple cortical areas revealed mildly hypercellular subcortical white matter with very mild vasogenic edema and rarefaction appreciated as patchy pale staining on LFB/PAS (Fig. 5A, B) . All areas of supratentorial, infratentorial, and spinal cord white matter showed a diffuse leukoencephalitis characterized by activation of CD68-positive microglia/macrophages (Fig. 5C ) and CD8-positive/TIA-1-positive/granzyme Bpositive cytotoxic T-cell infiltration (Fig. 5D, E) . Cortical gray matter was spared. Neurofilament immunostaining did not reveal axonal damage (Fig. 5F ). GFAP immunostaining highlighted moderate astrocyte dropout and diffuse astrocytopathy of the remaining cells. The astrocytes showed frequent short, swollen, and fragmented astrocytic processes throughout the white matter (Fig. 5G, H) . Classic features of clasmatodendrosis (cell body swelling and vacuolization with disintegration of the cell processes) were not prominent. There was no apparent dropout of oligodendroglial cells and OLIG2 staining showed no subjective decrease in density of oligodendrocyte nuclei in cortical gray or white matter. Double immunofluorescence staining for GFAP and Iba1 in midfrontal subcortical white matter confirmed the diffuse macrophage/microglial activation and significant astrocytopathy (Fig. 6A ), compared to autopsy brain tissue white matter from a separate case with similar postmortem time and formalin fixation (Fig. 6B) . GFAP-positive astrocyte processes were largely absent in the T-cell leukoencephalitis and astrocytopathy (TCLA) case (Fig. 6A ), compared to numerous process bearing astrocytes in the control case (Fig. 6B) . There was no evidence of phagocytosis of GFAP-positive material by macrophages. Double immunofluorescence labeling for GFAP and CD3 confirmed the restriction of the astrocytopathy and T-cell infiltration to white matter (Fig. 6C) , with sparing of cortical gray matter (Fig. 6D ). CD3-positive T cells were frequently found adjacent to dystrophic astrocytes (Fig. 6C) and were absent in cortical gray matter (Fig. 6D) . Immunohistochemical staining for AQP1 and AQP4 were performed. The usual staining patterns of AQP1 and AQP4 in cortical white matter greater than gray matter were lost, with disintegration of astrocyte process staining and replacement with diffuse light background staining.
In all sections examined, there was mild to moderate perivascular and leptomeningeal lymphocytic infiltration throughout the cerebral hemispheres, brainstem, cerebellum, and spinal cord in both gray and white matter. However, parenchymal T cells were restricted to white matter throughout the cerebrum (Fig. 5D ). The perivascular infiltrate was composed mostly of TIA-1-positive ( Unfortunately, the small portion of the optic nerve showing gross cavitation (Fig. 3B) was cut through while facing the block. The remaining portion of the posterior optic nerve and chiasm showed very mild vasogenic edema but no demyelination or loss of axons (Fig. 7A-C) . Inflammatory cell infiltrates were minimal in the nerve but the chiasm had prominent CD68-positive macrophages and CD8-positive T cells (Fig. 7D, E) , with associated astrocytopathy characterized by short and occasionally fragmented GFAP-positive cell processes (Fig. 7F) .
No gross abnormalities were noted in the brainstem (Sup plementary Data Fig. S2A ). However, microscopic sections from the central pons showed multiple foci of marked vacuolization characteristic of multifocal necrotizing leukoencephalopathy (Supplementary Data Fig. S2B, C) , without significant demyelination (Supplementary Data Fig. S2D ). These areas corresponded to areas of prominent CD68-positive macrophage/microglia (Supplementary Data Fig. S2E ). CD8-positive T cells were found in both gray and white matter within the pons (Supplementary Data Fig. S2F ). APP immunostaining marked distortion of axons in these lesions but at least some neurofilament staining was preserved (Supplemen tary Data Fig. S2G, H) .
In view of the clinical history of progressive cognitive decline, we evaluated for Alzheimer disease neuropathologic changes and other neurodegenerative processes. Sparse senile plaques were highlighted by amyloid immunostain and Bielschowsky preparation but neurofibrillary tangles were not apparent on hematoxylin and eosin (H&E) or phospho-tau immunostains (not shown). There were preserved pigmented neurons in the substantia nigra; Lewy bodies were not identified with H&E stain or a-synuclein immunohistochemistry. The possibility of a cryptic infection was also entertained but multiple immunostains for microorganisms were unrevealing.
DISCUSSION
Are the Clinical and Imaging Findings Compatible With NMO?
Based on the clinical presentation of acute myelitis with longitudinally extensive transverse lesions and area postrema syndrome, this patient's clinical and radiological findings support the clinical diagnosis of NMO spectrum disorder without serum AQP4-specific IgG (4). It should be noted that AQP4-IgG testing was performed on serum collected after the patient received high-dose steroids that can decrease titers below the detection threshold of current cell-based assays (10) . There was no documented clinical history of optic neuritis (nor was there MRI evidence), but unilateral optic nerve and chiasm lesions were present at autopsy (11) .
While the majority of the patient's clinical symptoms and signs were attributable to her extensive spinal cord disease, she also had significant cortical symptoms, as reported in other NMO patients (12, 13) . Given the absence of cortical gray matter pathology, her pronounced cognitive abnormalities are more readily attributed to cortical white matter pathology. MRI with contrast showed a striking radial pattern of deep periventricular enhancement in the white matter along the course of deep draining venules and/or penetrating arterioles, a pattern not previously reported in NMO (14) . Gadolinium-based contrast agents do not cross the intact blood-brain barrier, and only in the extravascular milieu does the T1 shortening effect of gadolinium result in T1 hyperintensity. Intravascular gadolinium-based contrast agents do not manifest as vascular enhancement due to the high concentration of gadolinium and resulting susceptibility effects under typical imaging parameters. This pattern of perivascular enhancement differs from typical demyelinating lesions, which appear as discrete, asymmetric and ovoid, rounded or ringshaped lesions in the white matter (12, 14) .
Is the Histopathology Compatible WIth NMO?
The pathology of NMO has been reviewed by Misu et al and categorized into 6 histopathological patterns (7). Of these, the spinal cord pathology of this TCLA case fits "type 5 lesions" (T-cell infiltration, no granulocytes or complement, astrocytopathy without abundant demyelination or axonal loss). The cord showed a highly destructive central lesion in cervical and thoracic regions. There was significant preservation of axons, many of which were myelinated and thus not characteristic of a demyelinative process such as multiple sclerosis. Despite the histopathological similarities with classic NMO descriptions, our patient's tissues showed neither complement deposition nor neutrophil or eosinophil infiltration, hallmarks of many previously described cases of NMO (8) .
Besides gross cavitation, perhaps the most striking feature of the spinal cord histopathology was the significant astrocytopathy (decreased number of cells, decreased number of processes, and dystrophic morphology), with extracellular edema and abundant intermediate filament debris. Because the remaining astrocytes were not coated with activated complement, it is difficult to discern what mediated the spinal cord destruction and astrocytopathy. Macrophages were present but insufficient in number or insufficiently activated to clear abundant cellular debris and intermediate filaments.
In view of the lack of clinical history of optic neuritis, the degree of optic chiasm involvement was impressive. A trend toward involvement of the posterior optic tract and chiasm in patients with NMO compared to MS has been reported in MRI studies during both acute attacks and in remission (11, 15, 16) , and lesions of the anterior visual pathway are found in a minority of patients with NMOSD without a previous history of optic neuritis (16) . Leptomeningeal and parenchymal optic nerve infiltration by T cells and macrophages, as seen in this case are reported features of NMOSD (16) , but the typical demyelinating lesions, AQP4 loss and complement deposition were not observed.
Cortical white matter pathology was much more subtle but exhibited a clear pathogenic mediator, that is, the infiltrate of activated CD8-positive T cells. Cognitive dysfunction and MRIdocumented edema and perivascular contrast enhancement were associated with the astrocytopathy in the absence of demyelination, which raised the intriguing hypothesis that activated cytotoxic T cells mediated the astrocytopathy as part of an autoimmune response or reaction to an unknown infectious agent affecting white matter astrocytes. In either case, what is left unexplained is why cortical gray matter astrocytes were not involved.
Pittock and Lucchinetti recently proposed renaming NMO spectrum disorders to, "autoimmune AQP4 channelopathies" to reflect the spectrum of inflammatory CNS demyelinating disease beyond the optic nerves and spinal cord (10) . If the current case can be subsumed under the rubric of NMOSD, this definition may need to be expanded to include cellular immunity targeting this CD8-positive TCLA should be considered a separate autoimmune disorder distinct from NMOSD and not defined by humoral mechanisms or the molecular target AQP4.
Opticospinal multiple sclerosis has similar and overlapping features with NMO, including selective and often severe involvement of the optic nerves and spinal cord, lesional T cells and macrophages, and astrocytopathy (19) . The neuropathologic findings in this case, however, cannot be categorized as multiple sclerosis because of the lack of demyelinating lesions and the longitudinally extensive nature of the myelitis not typical of MS. The clinical scenario would also be unusual for MS given the lack of oligoclonal bands in CSF and notable area postrema syndrome (1) .
These distinctions are not academic because the differences in histopathology imply differences in therapeutic approaches. Treatment of acute NMO has understandably focused on suppression and removal of pathogenic antibodies with corticosteroids and plasma exchange, with additional medications to prevent future attacks including azathioprine, mycophenolate, and rituximab. T-cell targeted therapies may also be required to suppress disease progression in a subset of NMO patients with predominantly T-cell autoreactivity.
Because this is the first autopsy report of CD8-positive TCLA presenting as NMOSD, we do not know how common this entity is clinically. Because of considerable variability in clinical presentation and laboratory assessment of NMOSD, it will be difficult to identify living patients with TCLA. CSF and serological findings are not pathognomonic, and while MRI findings in the spinal cord are striking, those in cortical white matter are more subtle and may be overlooked in the face of more dramatic cord abnormalities. Nevertheless, detecting TCLA in a living patient would permit more sophisticated immunologic testing and in particular assessment of cellular immunity.
